BNGO: Bionano Genomics Inc. filed SEC Form 8-K: Regulation FD Disclosure, Financial Statements and Exhibits
Stocks in this Quantisnow insightIndustrials
Historical context for BNGO
Across the 30 sessions after earlier BNGO headlines, the stock closed higher 14 times and lower 10 times, with a median move of 1.6% in either direction. This shows timing only: many things move a stock in a session, and these figures do not show that any headline caused a move.
| Session | Earlier headline | BNGO | SPY |
|---|---|---|---|
| Sep 10, 2026 | Bionano Laboratories Announces Proposed Local Coverage Determination (LCD) from MolDX for Genome-Wide Detection of Structural Variants in Hematologic Neoplasms | +1.7% | -0.6% |
| Sep 8, 2026 | Bionano Laboratories Announces New York State Department of Health Approval of Lab Developed Tests Based on Optical Genome Mapping | +0.0% | -0.5% |
| Aug 24, 2026 | Bionano to Participate in the H.C. Wainwright 28th Annual Global Investment Conference | +1.7% | -0.3% |
| Aug 11, 2026 | Bionano Reports Second Quarter 2026 Results and Provides a Business Update | +2.6% | -0.3% |
| Jul 28, 2026 | Bionano to Report Second Quarter 2026 Financial Results and Host a Conference Call Webcast on August 10, 2026 | +0.9% | +0.2% |
| Jun 24, 2026 | Bionano Announces Hiring of Chief Scientific Officer | -1.7% | -0.0% |
Quantisnow market dataNASDAQ
BNGO
Bionano Genomics Inc.
- Market cap
- 30-day
- Sector
- Industrials
- Industry
- Biotechnology: Laboratory Analytical Instruments
- Listed since
- 2018
Get push alerts for BNGO
Full BNGO profile on Quantisnow Follow BNGO and get a push notification the moment its next story breaks.
Original source Picked up and delivered by Quantisnow in real time